Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOICE: Adalimumab in Crohn's Disease After Infliximab Failure
NCT00338650Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Jun 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in Crohn's disease, sponsored by Abbott Laboratories. Started Jun 2006; status: completed.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00338650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00338650.